Adage Capital Partners’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-13,725,497
| Closed | -$9.47M | – | 1102 |
|
|
2020
Q4 | $9.47M | Sell |
13,725,497
-1,074,503
| -7% | -$742K | 0.02% | 604 |
|
|
2020
Q3 | $33.3M | Buy |
14,800,000
+1,084,159
| +8% | +$2.44M | 0.08% | 254 |
|
|
2020
Q2 | $49.1M | Buy |
13,715,841
+550,000
| +4% | +$1.97M | 0.13% | 186 |
|
|
2020
Q1 | $50M | Sell |
13,165,841
-5,221,199
| -28% | -$19.8M | 0.15% | 168 |
|
|
2019
Q4 | $55.3M | Buy |
+18,387,040
| New | +$55.3M | 0.14% | 189 |
|